In the 101 invasive carcinomas, expression of DEC1 was again nuclear but also cytoplasmic in 41 cases, and immunopositivity was stronger and more homogenous throughout the tumour than in normal or in situ carcinomas (Figure 1F). This evidence concerns the gene BHLHE40 and cancer.